vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and WM TECHNOLOGY, INC. (MAPS). Click either name above to swap in a different company.

AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $43.1M, roughly 1.0× WM TECHNOLOGY, INC.). WM TECHNOLOGY, INC. runs the higher net margin — -8.3% vs -19.9%, a 11.6% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -9.7%). WM TECHNOLOGY, INC. produced more free cash flow last quarter ($-280.0K vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -1.5%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

WM Entertainment is a South Korean entertainment company established in 2008 by former singer Lee Won-min. The company is responsible for managing artist Oh My Girl. On April 7, 2021, the company was acquired by RBW.

ABCL vs MAPS — Head-to-Head

Bigger by revenue
ABCL
ABCL
1.0× larger
ABCL
$44.9M
$43.1M
MAPS
Growing faster (revenue YoY)
ABCL
ABCL
+798.0% gap
ABCL
788.4%
-9.7%
MAPS
Higher net margin
MAPS
MAPS
11.6% more per $
MAPS
-8.3%
-19.9%
ABCL
More free cash flow
MAPS
MAPS
$44.3M more FCF
MAPS
$-280.0K
$-44.6M
ABCL
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
-1.5%
MAPS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABCL
ABCL
MAPS
MAPS
Revenue
$44.9M
$43.1M
Net Profit
$-8.9M
$-3.6M
Gross Margin
94.9%
Operating Margin
-63.7%
-13.5%
Net Margin
-19.9%
-8.3%
Revenue YoY
788.4%
-9.7%
Net Profit YoY
73.9%
-251.9%
EPS (diluted)
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
MAPS
MAPS
Q4 25
$44.9M
$43.1M
Q3 25
$9.0M
$42.2M
Q2 25
$17.1M
$44.8M
Q1 25
$4.2M
$44.6M
Q4 24
$5.0M
$47.7M
Q3 24
$6.5M
$46.6M
Q2 24
$7.3M
$45.9M
Q1 24
$10.0M
$44.4M
Net Profit
ABCL
ABCL
MAPS
MAPS
Q4 25
$-8.9M
$-3.6M
Q3 25
$-57.1M
$2.5M
Q2 25
$-34.7M
$1.4M
Q1 25
$-45.6M
$1.6M
Q4 24
$2.4M
Q3 24
$-51.1M
$3.3M
Q2 24
$-36.9M
$716.0K
Q1 24
$-40.6M
$1.2M
Gross Margin
ABCL
ABCL
MAPS
MAPS
Q4 25
94.9%
Q3 25
95.0%
Q2 25
94.9%
Q1 25
95.0%
Q4 24
95.2%
Q3 24
95.3%
Q2 24
95.1%
Q1 24
94.8%
Operating Margin
ABCL
ABCL
MAPS
MAPS
Q4 25
-63.7%
-13.5%
Q3 25
-851.8%
4.6%
Q2 25
-290.2%
4.4%
Q1 25
-1479.6%
5.9%
Q4 24
9.6%
Q3 24
-1439.4%
11.2%
Q2 24
-1276.2%
2.7%
Q1 24
-551.5%
8.5%
Net Margin
ABCL
ABCL
MAPS
MAPS
Q4 25
-19.9%
-8.3%
Q3 25
-637.8%
5.8%
Q2 25
-203.3%
3.2%
Q1 25
-1077.2%
3.7%
Q4 24
4.9%
Q3 24
-785.4%
7.2%
Q2 24
-504.3%
1.6%
Q1 24
-408.0%
2.8%
EPS (diluted)
ABCL
ABCL
MAPS
MAPS
Q4 25
$-0.03
Q3 25
$-0.19
Q2 25
$-0.12
Q1 25
$-0.15
$0.02
Q4 24
Q3 24
$-0.17
Q2 24
$-0.13
Q1 24
$-0.14
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
MAPS
MAPS
Cash + ST InvestmentsLiquidity on hand
$128.5M
$62.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$966.9M
$57.2M
Total Assets
$1.4B
$190.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
MAPS
MAPS
Q4 25
$128.5M
$62.4M
Q3 25
$83.2M
Q2 25
$92.4M
Q1 25
$159.3M
Q4 24
$156.3M
$52.0M
Q3 24
$126.6M
Q2 24
$148.3M
Q1 24
$123.6M
Stockholders' Equity
ABCL
ABCL
MAPS
MAPS
Q4 25
$966.9M
$57.2M
Q3 25
$964.0M
$56.9M
Q2 25
$1.0B
$52.7M
Q1 25
$1.0B
$48.5M
Q4 24
$1.1B
$36.1M
Q3 24
$1.1B
$29.5M
Q2 24
$1.1B
$24.5M
Q1 24
$1.1B
$20.8M
Total Assets
ABCL
ABCL
MAPS
MAPS
Q4 25
$1.4B
$190.7M
Q3 25
$1.4B
$192.9M
Q2 25
$1.4B
$188.1M
Q1 25
$1.3B
$183.8M
Q4 24
$1.4B
$181.9M
Q3 24
$1.4B
$173.6M
Q2 24
$1.4B
$168.0M
Q1 24
$1.5B
$165.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
MAPS
MAPS
Operating Cash FlowLast quarter
$-34.7M
$3.0M
Free Cash FlowOCF − Capex
$-44.6M
$-280.0K
FCF MarginFCF / Revenue
-99.4%
-0.7%
Capex IntensityCapex / Revenue
21.9%
7.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-174.1M
$13.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
MAPS
MAPS
Q4 25
$-34.7M
$3.0M
Q3 25
$-52.6M
$6.4M
Q2 25
$-32.4M
$11.1M
Q1 25
$-11.6M
$5.7M
Q4 24
$-108.6M
$9.4M
Q3 24
$-28.9M
$7.2M
Q2 24
$-30.0M
$12.7M
Q1 24
$-41.7M
$7.4M
Free Cash Flow
ABCL
ABCL
MAPS
MAPS
Q4 25
$-44.6M
$-280.0K
Q3 25
$-61.5M
$3.6M
Q2 25
$-45.8M
$8.2M
Q1 25
$-22.2M
$2.0M
Q4 24
$-187.0M
$7.3M
Q3 24
$-47.4M
$4.9M
Q2 24
$-50.1M
$10.1M
Q1 24
$-65.8M
$2.9M
FCF Margin
ABCL
ABCL
MAPS
MAPS
Q4 25
-99.4%
-0.7%
Q3 25
-687.0%
8.4%
Q2 25
-267.9%
18.3%
Q1 25
-524.0%
4.5%
Q4 24
-3702.8%
15.2%
Q3 24
-728.4%
10.4%
Q2 24
-683.8%
21.9%
Q1 24
-661.5%
6.4%
Capex Intensity
ABCL
ABCL
MAPS
MAPS
Q4 25
21.9%
7.7%
Q3 25
99.7%
6.8%
Q2 25
78.2%
6.3%
Q1 25
251.1%
8.2%
Q4 24
1552.7%
4.5%
Q3 24
284.6%
5.1%
Q2 24
274.6%
5.7%
Q1 24
242.5%
10.2%
Cash Conversion
ABCL
ABCL
MAPS
MAPS
Q4 25
Q3 25
2.61×
Q2 25
7.75×
Q1 25
3.44×
Q4 24
4.00×
Q3 24
2.17×
Q2 24
17.67×
Q1 24
5.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABCL
ABCL

Segment breakdown not available.

MAPS
MAPS

Services$39.5M92%
Other$3.6M8%

Related Comparisons